Journal of Gastrointestinal Surgery

, Volume 16, Issue 2, pp 382–388 | Cite as

P.O.P.A. Study: Prevention of Postoperative Abdominal Adhesions by Icodextrin 4% Solution After Laparotomy for Adhesive Small Bowel Obstruction. A Prospective Randomized Controlled Trial

  • Fausto Catena
  • Luca Ansaloni
  • Salomone Di Saverio
  • Antonio D Pinna
  • On Behalf of the World Society of Emergency Surgery
Original Article

Abstract

Background

Adhesive small bowel obstruction (ASBO) is an important cause of hospital admission, is associated with significant morbidity and mortality, and therefore is a substantial burden for healthcare systems worldwide. Icodextrin 4% solution (Adept, Shire Pharmaceuticals, UK) is a high-molecular-weight a-1,4 glucose polymer approved in Europe for use as intraoperative lavage and postoperative instillation to reduce the occurrence of post-surgery intra-abdominal adhesions. The present clinical study aimed to evaluate the safety and effectiveness of icodextrin 4% in decreasing the incidence, extent, and severity of adhesions in patients after abdominal surgery for ASBO.

Methods

The study was a single-center prospective, randomized investigation. The study is designed and conducted in compliance with the principles of Good Clinical Practice regulations. Safety and efficacy of icodextrin 4% in the study group are compared to no anti-adhesion treatment in a parallel control group with blinded evaluation of primary endpoints. Primary endpoints are the evaluation of the therapeutic role of icodextrin 4% in reducing ASBO recurrence incidence and the need of laparotomies for ASBO recurrence, as well as adhesion formation (with evaluation of their incidence, extent, and severity). A sum of 181 patients with ASBO and surgical indication to laparotomy were enrolled and randomized in two groups. Patients were submitted to adhesiolysis with bowel resection if required with or without anastomosis. The first group received traditional treatment (control group), whereas the second group was treated with the addition of icodextrin 4% solution before the abdominal closure.

Results

Ninety-one patients were randomized to have icodextrin 4% solution administered intraperitoneally, and 90 patients were randomized to have the traditional treatment. The two study groups were homogeneous regarding their baseline characteristics. The ASBO recurrence rate was 2.19% (2/91) in the icodextrin groups vs 11.11% (10/90) in the control group after a mean follow-up period of 41.4 months (p < 0.05). No differences were found in the need of laparotomies for ASBO recurrence in the studied groups. The adhesion severity score seems lower in the group treated with the addition of icodextrin (p = n.s.).

Conclusions

The data resulting from this RCT showed that the use of icodextrin 4% solution in ASBO is safe and reduces intra-abdominal adhesion formation and the risk of re-obstruction.

Keywords

Adhesive small bowel obstruction Abdominal adhesions Icodextrin Prevention of adhesions formation Randomized controlled trial 

References

  1. 1.
    Di Saverio S, Catena F, Ansaloni L, Gavioli M, Valentino M, Pinna AD. Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial. World J Surg. 2008;32(10):2293–304.PubMedCrossRefGoogle Scholar
  2. 2.
    Fevang BT, Fevang J, Lie SA, Soreide O, Svanes K, Viste A. Long term prognosis after operation for adhesive small bowel obstruction. Ann Surg 2004, 240(2):193–201.PubMedCrossRefGoogle Scholar
  3. 3.
    Ellis H. The clinical significance of adhesion: focus on intestinal obstruction. Eur J Surg Suppl 1997:5–9.Google Scholar
  4. 4.
    Di Saverio S, Tugnoli G, Catena F, Biscardi A, Baldoni F. Spiller R. A tenacious complete small bowel obstruction. Gut. 2009;58(6):812–891PubMedCrossRefGoogle Scholar
  5. 5.
    Menzies D. Prospective adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993, 75:147–53.PubMedGoogle Scholar
  6. 6.
    Ellis H: The magnitude of adhesion-related problems. Ann Chir Gynaecol 1998, 87:9–11.PubMedGoogle Scholar
  7. 7.
    Ray NF, Denton WG, Thamer M, Henderson SC, Perry S: Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994 J Am Coll Surg 1998,186:1–9PubMedCrossRefGoogle Scholar
  8. 8.
    Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2006;(2):CD001298Google Scholar
  9. 9.
    Verco SJ, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G. Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies. Hum Reprod. 2000;15(8):1764–72.PubMedCrossRefGoogle Scholar
  10. 10.
    Müller SA, Treutner KH, Anurov M, Titkova S, Oettinger AP, Schumpelick V. Experimental evaluation of phospholipids and icodextrin in re-formation of peritoneal adhesions. Br J Surg. 2003;90(12):1604–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Johnson DW, Agar J, Collins J, Disney A, Harris DC, Ibels L, Irish A, Saltissi D, Suranyi M. (2003) Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology (Carlton) 8(1):1–7.CrossRefGoogle Scholar
  12. 12.
    Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS; Adept Adhesion Reduction Study Group. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril. 2007 Nov;88(5):1413–26.PubMedCrossRefGoogle Scholar
  13. 13.
    diZerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D, Sanfilippo J, Peers EM, Scrimgeour A, Brown CB. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod. 2002 Apr;17(4):1031–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Catena F, Ansaloni L, Lauro A, Ercolani G, D'Alessandro L, Pinna A. Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences [POPA study: Prevention of Postoperative Adhesions on behalf of the World Society of Emergency Surgery]. Trials. 2008;9:74.PubMedCrossRefGoogle Scholar
  15. 15.
    Di Saverio S, Tugnoli G, Orlandi PE, Casali M, Catena F, Biscardi A, Pillay O, Baldoni F. A 73-year-old man with long-term immobility presenting with abdominal pain. PLoS Med. 2009 Jul 14;6(7):e1000092. Epub 2009 Jul 14Google Scholar
  16. 16.
    Diaz JJ Jr, Bokhari F et al. Guidelines for management of small bowel obstruction J Trauma. 2008;64(6):1651–64PubMedCrossRefGoogle Scholar
  17. 17.
    Eastern Association for the Surgery of Trauma Practice Parameter Workgroup for Management of Small Bowel Obstruction. Practice management guidelines for small bowel obstruction 2007. www.east.org
  18. 18.
    Catena F., Di Saverio S., Kelly M., Biffl W., Mandalà V., Ansaloni L, Velmahos G., Sartelli M., G. Tugnoli, M. Lupo, S. Mandalà, Pinna AD, Sugarbaker PH, H. VanGoor, Moore EE., Jeekel J. Bologna Guidelines for Diagnosis and Management of ADHESIVE SMALL BOWEL OBSTRUCTION: 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery World Journal of Emergency Surgery 2011, 6:5Google Scholar
  19. 19.
    Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS: Adept [icodextrin 4% solution] reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007, 88(5):1413–26.PubMedCrossRefGoogle Scholar
  20. 20.
    Baca B, Boler DE, Onur E, Akca O, Hamzaoglu I, Karahasanoglu T, Erdamar S, Atukeren P, Dirican A. Icodextrin and Seprafilm do not interfere with colonic anastomosis in rats. Eur Surg Res. 2007;39(5):318–23.PubMedCrossRefGoogle Scholar
  21. 21.
    van den Tol P, ten Raa S, van Grevenstein H, Marquet R, van Eijck C, Jeekel H. Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis. Surgery. 2005;137(3):348–54.PubMedCrossRefGoogle Scholar
  22. 22.
    Rodgers KE, Verco SJ, diZerega GS. Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbits. Colorectal Dis. 2003;5(4):324–30PubMedCrossRefGoogle Scholar
  23. 23.
    Kössi J, Grönlund S, Uotila-Nieminen M, Crowe A, Knight A, Keränen U. The effect of 4% icodextrin solution on adhesiolysis surgery time at the Hartmann's reversal: a pilot, multicentre, randomized control trial vs lactated Ringer's solution. Colorectal Dis. 2009;11(2):168–72PubMedCrossRefGoogle Scholar
  24. 24.
    Menzies D, Pascual MH, Walz MK, Duron JJ, Tonelli F, Crowe A, Knight A; ARIEL Registry. Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry. Ann R Coll Surg Engl. 2006;88(4):375–82.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2011

Authors and Affiliations

  • Fausto Catena
    • 1
  • Luca Ansaloni
    • 1
  • Salomone Di Saverio
    • 1
  • Antonio D Pinna
  • On Behalf of the World Society of Emergency Surgery
  1. 1.Department of General, Emergency and Transplant SurgerySt Orsola-Malpighi University HospitalBolognaItaly

Personalised recommendations